
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 95.940 | 95.940 | 0.000 |
Bonds | 0.180 | 0.180 | 0.000 |
Convertible | 0.160 | 0.160 | 0.000 |
Preferred | 3.680 | 3.680 | 0.000 |
Other | 0.070 | 0.170 | 0.100 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.853 | 20.853 |
Price to Book | 4.300 | 4.300 |
Price to Sales | 2.078 | 2.078 |
Price to Cash Flow | 18.525 | 18.525 |
Dividend Yield | 0.721 | 0.721 |
5 Years Earnings Growth | 10.431 | 10.431 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.930 | 99.930 |
Financial Services | 0.070 | 0.070 |
Number of long holdings: 270
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.27 | 761.31 | +3.64% | |
UnitedHealth | US91324P1021 | 6.21 | 379.42 | -0.32% | |
Intuitive Surgical | US46120E6023 | 5.88 | 557.73 | +3.96% | |
Thermo Fisher Scientific | US8835561023 | 4.61 | 430.79 | +6.86% | |
Stryker | US8636671013 | 4.23 | 389.33 | +2.21% | |
Danaher | US2358511028 | 3.77 | 199.30 | +5.04% | |
argenx ADR | US04016X1019 | 3.72 | 558.75 | +1.65% | |
Merck&Co | US58933Y1055 | 2.55 | 80.63 | +6.13% | |
Boston Scientific | US1011371077 | 2.54 | 102.57 | -0.28% | |
Vertex | US92532F1003 | 2.42 | 439.26 | +3.36% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TD North American Dividend I | 7.24B | -4.10 | 13.09 | 9.69 | ||
TD North American Dividend D USD | 7.24B | -3.78 | 14.24 | 10.60 | ||
TD U.S. Blue Chip Equity Fund D USD | 4.9B | -7.76 | 12.61 | - | ||
TD U.S. Blue Chip Equity Fund I USD | 4.9B | -8.08 | 11.50 | 11.44 | ||
TD US Index e | 3.08B | -8.87 | 14.50 | 13.21 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review